Harry Burn
Sound Shore Management
Sound Shore Management Portfolio 13F
Harry Burn Holdings Activity
- Portfolio value:
- $2.71B≈ (+$56M≈)
- Previous value:
- $2.66B≈
- # of changes:
- 39
- New positions:
- 4
- Reported for:
- 30 Jun 2023 (Q2)
- Latest filing date:
- 09 Aug 2023
Sound Shore Management has disclosed a total of 39 changes to the portfolio in the (2023 Q2) SEC report(s): increased the number of shares of 9, bought 4 totally new, decreased the number of shares of 24 and completely sold out 2 position(s).
What stocks did Harry Burn buy in 2023 Q2?
During 2023 Q2 Harry Burn has bought 13 securities out of which top 5 purchases (by % change to portfolio) were (MRK) Merck & Company Inc (added shares +12.17%), (HII) Huntington Ingalls Industries Inc (added shares +6.97%), (FDX) FedEx Corp (added shares +15.93%), (OGN) Organon & Co (added shares +13.35%) and (BA) The Boeing Company (added shares +2.38%).
In the 2023 Q2 report(s) the following changes have been made to the top investments: (FLEX) FLEX LTD (reduced shares -6.35%), (VST) Vistra Corp (reduced shares -2.51%), (NXPI) NXP SEMICONDUCTORS NV (reduced shares -3.32%), (WFC) Wells Fargo & Company (reduced shares -2.78%) and (COF) Capital One Financial Corp (reduced shares -1.34%).
39 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Roche Holding Ltd ADR
|
new
|
+1,437,613
|
1,437,613
|
+2.02%
|
$38.20
|
|
2.02%
|
2023 Q2
|
≈ 0.25 years
|
|
|
|
Analog Devices Inc
|
new
|
+342,209
|
342,209
|
+2.46%
|
$194.81
|
+98.33%($386.36)
|
2.46%
|
2023 Q2
|
≈ 0.25 years
|
|
|
|
Elevance Health Inc
|
new
|
+117,387
|
117,387
|
+1.92%
|
$444.29
|
-10.48%($397.73)
|
1.92%
|
2023 Q2
|
≈ 0.25 years
|
|
|
|
Fidelity National Information Services Inc
|
new
|
+1,050,900
|
1,050,900
|
+2.12%
|
$54.70
|
-22.12%($42.60)
|
2.12%
|
2023 Q2
|
≈ 0.25 years
|
|
|
|
Cisco Systems Inc
|
+25.07%
|
+265,159
|
1,322,701
|
+0.51%
|
$51.74
|
+140.12%($124.24)
|
2.52%
|
2023 Q1
|
≈ 0.50 years
|
|
|
|
Centene Corp
|
+19.94%
|
+170,750
|
1,027,218
|
+0.42%
|
$67.45
|
-1.56%($66.40)
|
2.55%
|
2023 Q1
|
≈ 0.50 years
|
|
|
|
FedEx Corp
|
+15.93%
|
+44,589
|
324,557
|
+0.41%
|
$247.90
|
+30.80%($324.25)
|
2.97%
|
2022 Q2
|
≈ 1.25 years
|
|
|
|
Organon & Co
|
+13.35%
|
+444,972
|
3,779,255
|
+0.34%
|
$20.81
|
-34.55%($13.62)
|
2.90%
|
2021 Q2
|
≈ 2.25 years
|
|
|
|
Merck & Company Inc
|
+12.17%
|
+81,465
|
750,745
|
+0.35%
|
$115.39
|
+13.27%($130.70)
|
3.19%
|
2015 Q2
|
≈ 8.25 years
|
|
|
|
Cleveland-Cliffs Inc
|
+9.38%
|
+359,754
|
4,194,564
|
+0.22%
|
$16.76
|
-24.97%($12.58)
|
2.59%
|
2022 Q3
|
≈ 1.00 year
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.